PIK3CA and neoplasm: In fact, aberrant signaling through the PI3K/AKT pathway, detected as increased AKT phosphorylation, occurs in approximately 70% of cases, and has been associated with poor prognosis, tumor recurrence and resistance to therapy [8,9].